Natera advances molecular diagnostics with integrity and scientific rigor, and supports integration of information provided by our tests into health care decision making.
Stock analysis for Natera Inc (NTRA:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
Natera Inc. Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services.
Natera Inc (NTRA:NSQ) company profile with history, revenue, mergers & acquisitions, peer analysis, institutional shareholders and more.
A detailed overview of Natera, Inc. (NTRA) stock, including real-time price, chart, key statistics, news, and more.
Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA (cfDNA) testing technology, with a focus on women's health, cancer, and organ health.
Natera, Inc. (NASDAQ:NTRA) is one of Billionaire Stan Druckenmiller’s 10 Small and Mid-Cap Stock Picks with Huge Upside Potential. Natera, Inc. (NASDAQ:NTRA) is the largest holding in the 13F ...
Natera's mission is to change the management of disease worldwide by using information gained from a simple blood draw to proactively inform treatment by using cell-free DNA (cfDNA) testing.
Morningstar: Natera to Scale AI Foundation Models in Precision Medicine with NVIDIA
Natera, Inc. (NASDAQ:NTRA), a global leader in cell-free DNA testing and precision medicine, today announced a new collaboration with NVIDIA to accelerate the development of Natera’s multimodal AI ...
Seeking Alpha: Natera Launches Proprietary AI Foundation Models to Accelerate Diagnostic and Therapeutic Innovation
Natera Launches Proprietary AI Foundation Models to Accelerate Diagnostic and Therapeutic Innovation